Clinical Data Collection of Patients Treated With High Intensity Focused Ultrasound (HIFU) by the Focal One for Their Prostate Cancer.

Abroad (travel likely)Recruiting

Conditions

Prostate Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Hôpital privé Aix en provence, Aix-en-Provence, France
Contact: Study coordinator (Dr BARRIOL, Dr) · david.barriol@gmail.com · +33442331764
Contact: Principal Investigator (David BARRIOL, Dr)
Clinique Saint vincent, Besançon, France
Contact: Study coordinator (Blandine Firek) · blandine.firek@gmail.com · +33 6 61 70 85 41
Contact: Principal Investigator (Vincent BAILLY, Dr)
Hôpital Civil Colmar, Colmar, France
Contact: Study coordinator (LOPEZ SANTIAGO, DR) · santiago.lopez@ch-colmar.fr · +33 389124520
Contact: Principal Investigator (Santiago LOPEZ, dr)
Hôpital Edouard Heriot, Lyon, France
Contact: Study coordinator (Marjolaine BEAUDOIN) · marjolaine.beaudoin@chu-lyon.fr · 0(33) 4 72 11 74 94
Contact: Principal Investigator (Sébastien CROUZET, Pr)
Clinique Nantes Atlantis, Nantes, France
Contact: Study coordinator (Cyrielle REGOIN) · cyrielle.leduin@sfr.fr · +33442331766
Contact: Principal Investigator (Eric POTIRON, Dr)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma

Biochemically Recurrent Prostate Carcinoma · Oligometastatic Prostate Carcinoma · Recurrent Prostate Adenocarcinoma

Abroad (travel likely)RecruitingPHASE3

Scottsdale, United States · Albert Lea, United States

Efficacy and Safety of Simultaneous Integrated Boost Radiotherapy in HR/VHR Prostate Cancer With EPLNI

Prostate Cancer Patients Treated by Radiotherapy

Abroad (travel likely)RecruitingPHASE2

Cairo, Egypt · Shibīn al Kawm, Egypt

A Study to Assess Adherence to Apalutamide in Metastatic Hormone-Sensitive Prostate Cancer Participants in France

Prostatic Neoplasms · Metastatic Hormone-sensitive Prostate Cancer

Abroad (travel likely)Recruiting

Caen, France

A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer

Metastatic Castration-resistant Prostate Cancer

Abroad (travel likely)RecruitingPHASE2

Phoenix, United States · Tucson, United States